Immunocore Holdings plc (IMCR)
 NASDAQ: IMCR · Real-Time Price · USD
 32.92
 +0.73 (2.27%)
  At close: Oct 31, 2025, 4:00 PM EDT
33.09
 +0.17 (0.52%)
  After-hours: Oct 31, 2025, 4:10 PM EDT
Immunocore Holdings Stock Forecast
Stock Price Forecast
The 8 analysts that cover Immunocore Holdings stock have a consensus rating of "Buy" and an average price target of $66.88, which forecasts a 103.16% increase in the stock price over the next year. The lowest target is $33 and the highest is $100.
Price Target: $66.88 (+103.16%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Immunocore Holdings stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | May '25 | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 | 
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 3 | 
| Buy | 4 | 4 | 4 | 4 | 2 | 3 | 
| Hold | 4 | 3 | 3 | 3 | 4 | 3 | 
| Sell | 0 | 0 | 0 | 0 | 0 | 0 | 
| Strong Sell | 1 | 1 | 1 | 1 | 1 | 0 | 
| Total | 11 | 10 | 10 | 10 | 9 | 9 | 
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date | 
|---|---|---|---|---|---|---|---|
| Wells Fargo | Wells Fargo | Buy Initiates $60 | Buy | Initiates | $60 | +82.26% | Oct 31, 2025 | 
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $100 | Strong Buy | Reiterates | $100 | +203.77% | Oct 22, 2025 | 
| Guggenheim | Guggenheim | Hold Initiates n/a | Hold | Initiates | n/a | n/a | Sep 18, 2025 | 
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $100 | Strong Buy | Reiterates | $100 | +203.77% | Jun 2, 2025 | 
| Oppenheimer | Oppenheimer | Buy Maintains $85 → $86 | Buy | Maintains | $85 → $86 | +161.24% | May 8, 2025 | 
Financial Forecast
Revenue This Year
 403.23M 
 from 310.20M
 Increased by 29.99%
Revenue Next Year
 438.92M 
 from 403.23M
 Increased by 8.85%
EPS This Year
 -0.75 
 from -1.02
EPS Next Year
 -1.36 
 from -0.75
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 
|---|---|---|---|---|---|
| High | 430.5M | 492.3M | |||
| Avg | 403.2M | 438.9M | |||
| Low | 362.8M | 391.9M | 
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 
|---|---|---|---|---|---|
| High | 38.8% | 22.1% | |||
| Avg | 30.0% | 8.9% | |||
| Low | 17.0% | -2.8% | 
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 
|---|---|---|---|---|---|
| High | -0.41 | -0.32 | |||
| Avg | -0.75 | -1.36 | |||
| Low | -1.38 | -2.82 | 
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - | 
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.